[HTML][HTML] SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
S Cele, L Jackson, DS Khoury… - … : the preprint server …, 2021 - pubmed.ncbi.nlm.nih.gov
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
[HTML][HTML] SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete… - 2021 - europepmc.org
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
S Cele, L Jackson, K Khan, DS Khoury, T Moyo-Gwete… - 2021 - pesquisa.bvsalud.org
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited
neutralization and requires ACE2 for infection | PREPRINT-MEDRXIV loading 1 2 3 +A A -A …
neutralization and requires ACE2 for infection | PREPRINT-MEDRXIV loading 1 2 3 +A A -A …
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete… - medRxiv, 2021 - medrxiv.org
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
S Cele, L Jackson, K Khan, DS Khoury, T Moyo-Gwete… - 2021 - pesquisa.bvsalud.org
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited
neutralization and requires ACE2 for infection | PREPRINT-MEDRXIV loading 1 2 3 +A A -A …
neutralization and requires ACE2 for infection | PREPRINT-MEDRXIV loading 1 2 3 +A A -A …
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection.
S Cele, L Jackson, DS Khoury, K Khan… - Medrxiv: the Preprint …, 2021 - europepmc.org
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
[HTML][HTML] SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
S Cele, L Jackson, K Khan, D Khoury, T Moyo-Gwete… - medRxiv, 2021 - medrxiv.org
The emergence of the Omicron variant (1) of SARS-CoV-2 in November 2021 in South Africa
has raised concerns that, based on the large number of mutations in the spike protein and …
has raised concerns that, based on the large number of mutations in the spike protein and …